Posts by: Marisa Wexler, MS

Marisa Wexler, MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

June 22, 2020June 22, 2020

Stem Cell-related Abnormalities May Predict Recurrence in Crohn’s Disease

Crohn's Disease, News

Abnormalities in intestinal stem cell niches may predict recurrence in Crohn’s disease, a new study suggests. These irregularities may result from problems with mitochondria — the so-called powerhouse of ... Read more

May 18, 2020May 18, 2020

Early Phase 2 Trial Data Support Safety, Efficacy of BBT-401 for Ulcerative Colitis

News, Ulcerative colitis

People with ulcerative colitis may benefit from the experimental oral therapy BBT-401, suggest early data from an ongoing Phase 2 clinical trial that also supports its good safety profile. BBT-401 ... Read more

May 11, 2020May 11, 2020

Entyvio At-home Injection Approved in Europe to Treat Adults With IBD

Crohn's Disease, News, Ulcerative colitis

The European Commission has approved a subcutaneous (under-the-skin) formulation of Entyvio (vedolizumab) for use as maintenance therapy in adults with moderately to severely active ulcerative colitis (UC) or Crohn’s disease (CD). ... Read more

April 13, 2020April 13, 2020

Etrasimod in Controlled Release Seen to Limit Heart Rate Changes, May Be Added to Trials

News

A controlled-release version of etrasimod could limit the changes in heart rate linked to an initial dose of this investigational medication, according to topline clinical trial data announced by ... Read more

March 16, 2020March 16, 2020

Immunosuppressive Therapy Does Not Increase Vaginal Cancer Risk, Study Finds

News

Therapies that suppress the immune system do not increase the risk of vulvar or vaginal cancer in women with inflammatory bowel disease (IBD), a new study has found. The ... Read more

January 8, 2020January 8, 2020

People With IBD At Higher Risk Of Serious Viral Infections, Study Suggests

News

Adults with inflammatory bowel disease (IBD) have an increased risk of serious viral infections compared to the general population, a study suggests. This risk was found to be highest ... Read more

October 9, 2019October 9, 2019

Interim Analysis Suggests Wider-than-expected Dosing Range for IMU-838 to Treat Ulcerative Colitis

News

Interim analysis of a Phase 2 clinical trial that’s investigating IMU-838 in people with ulcerative colitis (UC) suggests a broader dose range than initially anticipated, announced the therapy’s developer, ... Read more

October 7, 2019October 7, 2019

Diet Low in Fermented Sugars May Ease IBD Symptoms, Study Reports

News

A diet that is low in fermented sugars may help alleviate symptoms of inflammatory bowel disease (IBD), a study suggests. The study, “Effects of Low-FODMAP Diet on Symptoms, Fecal ... Read more

September 27, 2019September 27, 2019

Innate Biologics Granted Patent for Modified Anti-inflammatory Bacterial Proteins

News

Innate Biologics has been granted a U.S. patent for its bacterial protein-based anti-inflammatory technology, the company announced in a press release. The technology is based off of bacterial E3 ... Read more

September 18, 2019September 17, 2019

FTC Warns Companies Against Unsubstantiated Advertising of CBD Products for IBD

News

The U.S. Federal Trade Commission (FTC) sent warning letters to three companies that sell cannabis-based products containing cannabidiol (CBD), cautioning them that making unsubstantiated claims about the health benefits ... Read more